Olaparib routine clinical practice in Germany - Quality of life interim results of the non-interventional C-PATROL study

被引：0

作者：

El-Balat, A. ^{[1
]}

Marme, F. ^{[2
]}

Sehouli, J. ^{[3
]}

Welslau, M. ^{[4
]}

Grabowski, J. P. ^{[5
,6
]}

Hartkopf, A. ^{[7
]}

Glowik, R. ^{[8
]}

Hilpert, F. ^{[9
]}

机构：

[1] Univ Klinikum Frankfurt, Klin Frauenheilkunde & Geburtshilfe, Frankfurt, Germany

[2] Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Gynecol, Mannheim, Germany

[3] Charite, Ctr Oncol Surg, Dept Gynecol, Berlin, Germany

[4] Med Off Hematooncol, Aschaffenburg, Aschaffenburg, Germany

[5] Charite, Dept Gynecol, Berlin, Germany

[6] Charite, Ctr Oncol Surg, Berlin, Germany

[7] Univ Hosp Tuebingen, Ctr Womens Hlth, Tubingen, Germany

[8] AstraZeneca Germany, Oncol, Wedel, Germany

[9] Jerusalem Hosp Hamburg, Ctr Oncol, Hamburg, Germany

来源：

GEBURTSHILFE UND FRAUENHEILKUNDE | 2020年 / 80卷 / 10期

关键词：

D O I：

10.1055/s-0040-1718133

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

P304

引用

页码：E188 / E188

页数：1

共 50 条

[41] The Antidepressant Agomelatine in Daily Practice: Results of the Non-Interventional Study VIVALDI [J].

Laux, G. .

PHARMACOPSYCHIATRY, 2012, 45 (07) :284-291

[42] Effectiveness, Safety and Quality of Life with Tofacitinib Treatment in Adult Patients with Rheumatoid Arthritis Under Routine Clinical Care: First Interim Results from a German Non-Interventional, Prospective, Multi-Center Study [J].

Behrens, Frank ;

Prothmann, Ulrich ;

Klopsch, Thilo ;

Holst, Ann-Doerthe ;

Blindzellner, Lisa ;

Behmer, Olaf ;

Klaus, Pascal ;

Meng, Thomas ;

Loeschmann, Peter-Andreas .

ARTHRITIS & RHEUMATOLOGY, 2020, 72

[43] Efficacy and Tolerability of Certolizumab pegol for the Treatment of rheumatoid Arthritis in clinical Practice in Germany: 3rd Interim Analysis of non-interventional Study "Fast" [J].

Burmester, G. ;

Mueller-Ladner, U. ;

Nuesslein, H. ;

von Hinueber, U. ;

Edelmann, E. ;

Detert, J. ;

Hoehle, M. ;

Richter, C. ;

Klopsch, T. ;

Kumke, T. ;

Fricke, D. .

ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 :100-100

[44] Efficacy and safety of tirbanibulin in actinic keratoses. Interim results of a non-interventional study [J].

Heppt, M. ;

Hadshiew, I. ;

Kempf, A. ;

Melzer, A. ;

Berking, C. .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 :69-70

[45] Interim results of the phase IV JAKoMo trial, a prospective, non-interventional study of symptoms and quality of life in myelofibrosis patients receiving ruxolitinib therapy [J].

Wehrle, J. ;

Geer, T. ;

Brudler, O. ;

Schaefer, E. ;

Tesch, H. ;

Cavanna, D. ;

Bachhuber, P. ;

Markhauser, M. ;

Koschmieder, S. ;

Mesa, R. A. ;

Pahl, H. L. .

Oncology Research and Treatment, 2015, 38 :227-228

[46] Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI - Interim results of the non-interventional AIO study QoLiTrap [J].

von Moos, R. ;

Derigs, G. ;

Scholten, F. ;

Thaler, J. ;

Losem, C. ;

Kroening, H. ;

Windemuth-Kieselbach, C. ;

Hofheinz, R. D. .

ANNALS OF ONCOLOGY, 2017, 28

[47] Analysis of the quality of life in patients treated with Aflibercept and FOLFIRI for metastatic colorectal cancer (mCRC) - Interim results from the non-interventional QoLiTrap study [J].

Derigs, H. -G ;

Scholten, F. ;

Losem, C. ;

Kroening, H. ;

Windemuth-Kieselbach, C. ;

Hofheinz, R. -D .

Oncology Research and Treatment, 2015, 38 :61-62

[48] Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI: Interim results of the non-interventional AIO study QoLiTrap [J].

Zahn, M. ;

Scholten, F. ;

von Moos, R. ;

Thaler, J. ;

Hofheinz, R. .

ANNALS OF ONCOLOGY, 2018, 29

[49] Efficacy of Afatinib in the clinical practice - first results of the GIDEON trial: a prospective non-interventional study (NIS) in EGFR mutated NSCLC in Germany [J].

Rawluk, J. ;

Reck, M. ;

Laack, E. ;

Griesinger, F. ;

Schaefer, H. ;

Kortsik, C. ;

Gaska, T. ;

Krueger, S. ;

Kokowski, K. ;

Budweiser, S. ;

Schueler, A. ;

Hoffmann, C. ;

Brueckl, W. .

ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 :210-211

[50] Efficacy of afatinib in the clinical practice: First results of the GIDEON trial: A prospective non-interventional study (NIS) in EGFR mutated NSCLC in Germany [J].

Brueckl, M. ;

Laack, E. ;

Reck, M. ;

Griesinger, F. ;

Schaefer, H. ;

Kortsik, C. ;

Gaska, T. ;

Rawluk, J. ;

Krueger, S. ;

Kokowski, K. ;

Budweiser, S. ;

Schueler, A. ;

Kiessling, S. .

ANNALS OF ONCOLOGY, 2018, 29 :524-524

← 1 2 3 4 5 →